10 January 2020
Returning for its 3rd annual edition, the 2020 PharmaSynergy conference and partnering meetings will take place on 24-25th February in London.
PharmaSynergy is a combination of pre-arranged partnering meetings and a conference highlighting global growth regions and topics such as internalisation, portfolio, alliances, commercial and in/out-licensing opportunities. For the third year, we are gathering senior executives from major national companies from Europe and around the globe, as well as CEOs of mid-size European and specialty pharma and senior BD&L and portfolio executives. PharmaSynergy has a very strong focus on emerging markets with delegations coming from Europe, LatAm, CEE, Russia & CIS, APAC & MENA.
11.5 hours of meetings: The one-to-one meetings are 30 minutes in length, timed and agreed with the participants in advance via our networking platform.
Focused and facilitated approach: We value your time. To help you select who to meet, we ask our delegates to submit information that will narrow-down the best partnering options for you.
Arrange for one-to-one meetings with: Gedeon Richter, Salvat, Italfarmaco, Sandoz, Zentiva, Eurofarma, Aurobindo Pharma, Egis Pharmaceuticals, Ethypharm, Stendhal Pharma, Mundipharma, Amring Pharmaceuticals, FAES, BioXtract, CLINIGEN, Inpha Duemila il Dott, Yuria-Pharm, Masters Speciality Pharma, ABC FARMACEUTICI, Farmatek Pharmaceuticals, Tecnimede Group, and many more. See the full list of companies here
Key topics include:
- Internationalisation and Growth Strategies
- Creating Value through Asset Acquisitions
- Commercial Alliances and Licensing Deals
- Cross-Border Product Portfolio Adaptation
- Global Market Opportunities